LEDDA, ROBERTA EUFRASIA
 Distribuzione geografica
Continente #
NA - Nord America 1.916
AS - Asia 1.494
EU - Europa 969
SA - Sud America 282
AF - Africa 90
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.754
Nazione #
US - Stati Uniti d'America 1.866
SG - Singapore 720
CN - Cina 314
BR - Brasile 229
IT - Italia 221
HK - Hong Kong 186
IE - Irlanda 142
SE - Svezia 142
VN - Vietnam 123
DE - Germania 122
NL - Olanda 77
ZA - Sudafrica 61
FI - Finlandia 46
GB - Regno Unito 45
AT - Austria 38
RU - Federazione Russa 34
IN - India 28
FR - Francia 25
AR - Argentina 23
CA - Canada 22
PL - Polonia 20
BD - Bangladesh 19
MX - Messico 18
KR - Corea 14
TR - Turchia 14
ID - Indonesia 12
ES - Italia 10
IR - Iran 9
JP - Giappone 9
MA - Marocco 9
UA - Ucraina 9
BE - Belgio 8
BG - Bulgaria 8
CI - Costa d'Avorio 8
EC - Ecuador 8
PK - Pakistan 8
PY - Paraguay 8
AE - Emirati Arabi Uniti 7
IQ - Iraq 7
CL - Cile 5
UZ - Uzbekistan 5
VE - Venezuela 5
CZ - Repubblica Ceca 4
RO - Romania 4
AZ - Azerbaigian 3
CO - Colombia 3
DO - Repubblica Dominicana 3
EG - Egitto 3
KE - Kenya 3
TN - Tunisia 3
CH - Svizzera 2
GE - Georgia 2
IL - Israele 2
KG - Kirghizistan 2
LB - Libano 2
LT - Lituania 2
SA - Arabia Saudita 2
TT - Trinidad e Tobago 2
AL - Albania 1
AU - Australia 1
BF - Burkina Faso 1
BH - Bahrain 1
DK - Danimarca 1
GD - Grenada 1
GI - Gibilterra 1
GR - Grecia 1
GT - Guatemala 1
HR - Croazia 1
HU - Ungheria 1
JM - Giamaica 1
JO - Giordania 1
MD - Moldavia 1
ME - Montenegro 1
MK - Macedonia 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
SY - Repubblica araba siriana 1
TZ - Tanzania 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.754
Città #
Singapore 368
Dallas 351
Ashburn 307
Chandler 210
Hong Kong 186
Santa Clara 150
Dublin 142
Beijing 101
Boardman 92
Johannesburg 59
New York 58
Munich 55
Ho Chi Minh City 51
Los Angeles 51
Shanghai 48
Milan 40
Parma 39
Helsinki 38
Ann Arbor 37
Hanoi 27
Vienna 27
São Paulo 25
Moscow 23
Princeton 22
Frankfurt am Main 18
London 18
Buffalo 16
Warsaw 15
Columbus 14
Hefei 14
Nuremberg 14
Rome 14
Bologna 13
Chicago 13
San Giuliano Milanese 13
Denver 12
Seoul 12
Seattle 11
The Dalles 11
Amsterdam 10
Des Moines 10
Belo Horizonte 9
Bremen 9
Fremont 9
San Francisco 9
Toronto 9
Abidjan 8
Boston 8
Brussels 8
Redondo Beach 8
Tokyo 8
Brasília 7
Brooklyn 7
Chennai 7
Haiphong 7
Houston 7
Phoenix 7
Poplar 7
Rio de Janeiro 7
Stockholm 7
Tehran 7
Turku 7
Wilmington 7
Atlanta 6
Charlotte 6
Düsseldorf 6
Jakarta 6
Kocaeli 6
Mexico City 6
Sofia 6
Ankara 5
Casablanca 5
Curitiba 5
Fortaleza 5
Guangzhou 5
Hải Dương 5
Lahore 5
Montreal 5
Orem 5
Santo André 5
Tashkent 5
Asunción 4
Biên Hòa 4
Brescia 4
Edinburgh 4
Florence 4
Fort Worth 4
Goiânia 4
Grafing 4
Guayaquil 4
Manchester 4
Maracaibo 4
Nanjing 4
Ottawa 4
Porto Alegre 4
Springfield 4
Trento 4
Baku 3
Collecchio 3
Da Nang 3
Totale 3.074
Nome #
Validation of a radiomic approach to decipher NSCLC immune microenvironment in surgically resected patients 181
Association of hepatic steatosis with epicardial fat volume and coronary artery disease in symptomatic patients 164
1352P A highly predictive blood-radiomics classifier in advanced NSCLC treated with immunotherapy 162
17P Dynamic changes of CT-radiomic and systemic immune-inflammatory features predict the response to immune checkpoint inhibitors in advanced NSCLC patients 138
Dynamic Profiling of Blood Immunophenotypes and Radiomic Features to Predict Immunotherapy Response in Advanced Non-small Cell Lung Cancer 136
Approach to diffuse lung diseases: dilemmas, pitfalls and tips 125
Frequency and characterization of ancillary chest CT findings in COVID-19 pneumonia 121
A low-dose CT-based radiomic model to improve characterization and screening recall intervals of indeterminate prevalent pulmonary nodules 117
Validity of epicardial fat volume as biomarker of coronary artery disease in symptomatic individuals: Results from the ALTER-BIO registry 115
Pros and cons of reporting incidental findings in lung cancer screening 111
A Multiclass Radiomics Method-Based WHO Severity Scale for Improving COVID-19 Patient Assessment and Disease Characterization From CT Scans 107
Clinical Impact of COVID-19 Outbreak on Cancer Patients: A Retrospective Study 106
MR-based simplified extraprostatic extension evaluation: comparison of performances of different predictive models 100
P1.15-04 Dynamic Profiling of Blood Immunophenotypes and Radiomic Features to Predict Immunotherapy Response in Advanced Non-small Cell Lung Cancer 97
The role of the radiologist in diagnosing the covid-19 infection. Parma experiences 97
Interstitial lung abnormalities: new insights between theory and clinical practice 97
Study rationale and design of the PEOPLHE trial 93
Automated Coronary Artery Calcium and Quantitative Emphysema in Lung Cancer Screening: Association With Mortality, Lung Cancer Incidence, and Airflow Obstruction 93
Diameter versus volumetry: A narrative review on current recommendations to measure and monitor screening detected lung nodules 92
Integrated Radiologic Algorithm for COVID-19 Pandemic 90
Lung Cancer Screening: Evidence, Risks, and Opportunities for Implementation 87
The diagnostic value of grey-scale inversion technique in chest radiography 87
Interstitial Lung Abnormalities on Unselected Abdominal and Thoracoabdominal CT Scans in 21 118 Patients 86
European lung cancer screening: valuable trial evidence for optimal practice implementation 84
Percutaneous injection of sclerosant agents as an effective treatment for cystic malformations of the head and neck 83
Spread through air spaces in lung adenocarcinoma: Is radiology reliable yet? 83
Imaging in non-cystic fibrosis bronchiectasis and current limitations 82
Airway Diseases in Geriatric Patients 81
A fully automated micro‑CT deep learning approach for precision preclinical investigation of lung fibrosis progression and response to therapy 79
Diagnostic performance of chest CT average intensity projection (AIP) reconstruction for the assessment of pleuro-parenchymal abnormalities 78
The pros and cons of lung cancer screening 73
Screen-detected solid nodules: from detection of nodule to structured reporting 70
The radiological appearances of lung cancer treated with immunotherapy: a review 69
PREVALENCE, INCIDENCE AND SURVIVAL IN INTERSTITIAL LUNG DISEASE SECONDARY TO PRIMARY SJOGREN'S SYNDROME. RESULTS FROM THE "EMERGE" LONGITUDINAL STUDY 66
Volumetric Measurements in Lung Cancer Screening Reduces Unnecessary Low-Dose Computed Tomography Scans: Results from a Single-Center Prospective Trial on 4119 Subjects 66
The added value of an AI-based body composition analysis in a lung cancer screening population: preliminary results 66
Cytisine Therapy Improved Smoking Cessation in the Randomized Screening and Multiple Intervention on Lung Epidemics Lung Cancer Screening Trial 65
Might EAT composition help to predict coronary artery disease severity? 65
A New Challenge for Radiologists: Radiomics in Breast Cancer 61
Feasibility and Safety of Lung Cancer Screening and Prevention Program During the COVID-19 Pandemic 61
P57.08 High Performance Radiomic Classifier to Predict the Response to Immunotherapy in Advanced NSCLC 60
Erdheim-Chester disease presenting with cough, abdominal pain, and headache 58
Ultra-low dose computed tomography protocols using spectral shaping for lung cancer screening: Comparison with low-dose for volumetric LungRADS classification 54
Automated Measurement of Coronary Artery Calcifications and Routine Perioperative Blood Tests Predict Survival in Resected Stage I Lung Cancer 53
Concurrent pulmonary embolism in female monozygotic twins affected by Dercum's disease 52
Predicting Future Lung Cancer Risk from a Single Low-Dose CT Using Deep Learning 52
Fully automated calcium scoring predicts all-cause mortality at 12 years in the MILD lung cancer screening trial 49
Surveillance of subsolid nodules avoids unnecessary resections in lung cancer screening: long-term results of the prospective BioMILD trial 47
Esophageal stent migration: A report of two cases 44
Evaluation of e-Lung automated quantitative computed tomography biomarkers in idiopathic pulmonary fibrosis 41
Prior knowledge-guided vision-transformer-based unsupervised domain adaptation for intubation prediction in lung disease at one week 41
Is there a high-risk mammographic pattern in b3 lesions? 41
Progress in the radiologic diagnosis of idiopathic pulmonary fibrosis 40
Blood microRNA testing in participants with suspicious low-dose CT findings: follow-up of the BioMILD lung cancer screening trial 39
The Unveiled Triad: Clinical, Radiological and Pathological Insights into Hypersensitivity Pneumonitis 38
Management of visceral artery aneurisms: A pictorial essay 38
Hunting imaging biomarkers in pulmonary fibrosis: Benchmarks of the AIIB23 challenge 36
Coronary calcium score and emphysema extent on different CT radiation dose protocols in lung cancer screening 35
Radiomics in breast cancer 34
Long-term outcomes of lung cancer screening in males and females 31
Role of thoracic imaging in the management of lymphangioleiomyomatosis 31
ITA-IMMUNO-PET: The Role of [18F]FDG PET/CT for Assessing Response to Immunotherapy in Patients with Some Solid Tumors 29
High resolution computed tomography in systemic sclerosis: From diagnosis to follow-up 26
Longitudinal blood immune-inflammatory and radiomic profiling to decode different patterns acquired resistance to immunotherapy in patients with NSCLC 26
Totale 4.829
Categoria #
all - tutte 20.038
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.038


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202198 0 0 0 0 0 1 12 18 15 14 23 15
2021/2022170 11 10 25 2 8 6 36 8 4 1 18 41
2022/2023711 70 89 35 75 65 77 10 50 180 15 31 14
2023/2024358 25 27 22 6 43 73 41 14 19 18 26 44
2024/20251.339 18 72 181 58 106 109 56 56 123 144 122 294
2025/20262.136 330 354 521 327 501 103 0 0 0 0 0 0
Totale 4.829